InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,865.00
(
0.01%
)
US TECH 100
19,804.00
(
0.13%
)
Dow Jones
43,188.60
(
-0.20%
)
Brent Oil
73.69
(
1.06%
)
Bitcoin
67,476.81
(
-2.21%
)

Replies to post #2330 on Anthera Pharmaceuticals Inc (ANTH)

Replies to #2330 on Anthera Pharmaceuticals Inc (ANTH)
icon url

Value_Investor

04/06/18 5:14 PM

#2368 RE: blukky #2330

Anthera Pharmaceuticals, Inc. plans to evaluate all strategic alternatives in order to maximize shareholder value.



The best strategy for the company now is to sell ANTH which should value each common share at $0.60 at least, instead of continuing its other drugs R&D.